跳至主要内容
临床试验/CTRI/2023/01/048718
CTRI/2023/01/048718尚未招募未知

Treatment response to Fluoxetine in Obsessive Compulsive Symptoms in Schizophrenia

Government Medical College and Hospital Chandigarh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Patients with diagnosis of Schizophrenia as per ICD 11 and presence of Obsessive Compulsive Symptoms as per Yale Brown Obsessive Compulsive Symptom Checklist
  • 2 Patients having capacity as per Section 4 of Mental Health Care Act 2017 to give written consent or Nominated Representative agreeing to give written consent when the patient does not have adequate capacity
  • 3 Patients on stable dose of antipsychotic medications for the past 3 months (no more than 50% reduction or increase in antipsychotic medications)
  • 4 Age 18 to 65 years
  • 5 Any gender

排除标准

  • 1 Patients with active substance use disorder within the past 6 months (fulfilling the ICD 11 criteria for substance dependance) except caffeine and nicotine
  • 2 Patients with any acute medical or surgical illness or receiving concomitant medications with contraindications to Fluoxetine
  • 3 Pregnant and Lactating patients
  • 4 Actively suicidal patients or those having high suicidal risk currently
  • 5 Patients already on SSRI and/or Clomipramine for any other co morbid psychiatric condition
  • 6 Patients receiving non pharmacological intervention like ERP or CBT

研究者

发起方
Government Medical College and Hospital Chandigarh

相似试验